Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00836290 · ClinicalTrials.gov registry record · NA

Positive Lifestyles Using Safety

A NA study of HIV Infections and HIV, sponsored by Yale University.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT00836290: Completed NA study of HIV Infections and HIV, sponsored by Yale University.

NCT00836290 is a NA study of HIV Infections and HIV that has completed, run by Yale University. The registered enrollment target is 90 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00836290, a NA study of HIV Infections and HIV, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Project PLUS tests an HIV risk reduction/adherence behavioral intervention with HIV-infected individuals in Connecticut prisons. Participants are randomly assigned to one of three groups: prior to release from incarceration (Group 1), after release from incarceration (Group 2), and treatment-as-usual (Group 3). We hypothesize that the intervention groups (Groups 1 \& 2) will demonstrate significantly greater knowledge regarding drug- and sex- related HIV risk behavior and HIV medication adherence, greater motivation to reduce HIV risk behavior and improve HIV medication adherence, and enhanced skills for engaging in HIV risk reduction behavior and HIV medication adherence vs. the treatment-as-usual group. We will also compare these outcomes between Groups 1 and 2.

Conditions Studied

Interventions

  • BEHAVIORAL Pre-Release (Group 1)
  • BEHAVIORAL Post-release (Group 2)

Study Locations (1)

Connecticut

  • Yale AIDS Program, Yale University School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2008-01
Est. Completion 2010-08
Phase NA
Yale University

1,492 total trials

What the finished NCT00836290 record still lists

NCT00836290 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (80% lower).

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Pre-Release (Group 1) is the first listed.

NCT00836290 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT00836290 about?

NCT00836290 is a clinical study titled "Positive Lifestyles Using Safety". Project PLUS tests an HIV risk reduction/adherence behavioral intervention with HIV-infected individuals in Connecticut prisons. Participants are randomly assigned to one of three groups: prior to release from incarceration (Group 1), after release from incarceration (Group 2), and treatment-as-usua...

What is the current status of trial NCT00836290?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2008-01. Estimated completion is 2010-08.

What conditions does trial NCT00836290 study?

This clinical trial studies the following conditions: HIV Infections, HIV.

What interventions are being tested in trial NCT00836290?

The interventions under investigation include: Pre-Release (Group 1) (BEHAVIORAL), Post-release (Group 2) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00836290?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00836290 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00836290's enrollment target sits among peer trials

90 287th of 542 higher than 251 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00836290, the US trial registry maintained by the National Library of Medicine. NCT00836290 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.